Abstract
In 1960, Richards (1) was the first to suggest that technetium-99m might have useful medical applications. Soon after that, the isotope was introduced for brain and thyroid scanning. The ability of the salivary glands to concentrate 99mTc-pertechnetate had been recognized since the early days of brain scanning. Yet this phenomenon was initially considered a nuisance because it interfered with a proper interpretation of the cerebral structures. However, it was soon realized that active concentration of pertechnetate by the salivary glands provided a welcome opportunity to investigate various diseases of these organs and the first article dedicated to salivary gland scintigraphy with 99mTc-pertechnetate was published by Borner et al. in 1965 (2). In the following years, a large number of publications on the subject appeared in the international literature. This flow indicated a lively interest in the new procedure at a time when, from a practical point of view, only plain radiography and sialography were available to evaluate salivary gland disorders.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Richards P. A survey of the production at Brookhaven National Laboratory of isotopes for medical research. In: V Congresso Nucleare, vol. 2. Rome: Comitato Nazionale Ricerche Nucleari, 1960: 225–244.
Börner W, Grünberg H, Moll E. Die szintigraphische darstellung der kopfspeicheldrüsen mit Technetium-99m. Med Welt 1965; 42: 2378–2380.
Busemann-Sokole E, Van den Akker HP, Van der Schoot JB. Sequential salivary gland scintigraphy using technetium-99m and carbachol: a clinical test. In: Medical Radionuclide Imaging, vol. 2. Vienna: International Atomic Energy Agency, 1977: 363–369.
Van den Akker HP, Busemann-Sokole E, Van der Schoot JB. Origin and location of the oral activity in sequential salivary gland scintigraphy with 99mTc-pertechnetate. J Nucl Med 1976; 17: 959–964.
Schall GL, Anderson LG, Wolf RO, Herdt JR, Tarpley TM, Cummings NA, et al. Xerostomia in Sjögren’s syndrome. Evaluation by sequential salivary scintigraphy. JAMA 1971; 216: 2109–2116.
Daniels TE, Powell MR, Sylvester RA, Talal N. An evaluation of salivary scintigraphy in Sjögren’s syndrome. Arthritis Rheum 1979; 22: 809–814.
Katz WA, Ehrlich GE, Gupta VP, Shapiro B. Salivary gland dysfunction in systemic lupus erythematosus and rheumatoid arthritis. Arch Intern Med 1980; 140: 949–951.
Janin-Mercier A, Sauvezie B, Ristori JM, Betail G, Veyre A, Rampon S. Histological and immunological study in patients with rheumatoid arthritis showing isolated abnormalities of salivary scintigraphy. J Clin Immunol 1982; 2: 282–288.
Schall GL, Larson SM, Anderson LG, Griffith JM. Quantification of parotid gland uptake of pertechnetate using a gamma scintillation camera and a ‘region of interest’ system. AJR Am J Roentgenol 1972; 115: 689–697.
Fox PC, Bodner L, Bowers MR, Baum BJ. Uptake and secretion of technetium pertechnetate by the rat parotid gland. Comp Biochem Physiol 1986; 83A: 579–584.
Hug I. Die nuklearmedizinische funktionsdiagnostik der parotis. I. Die funktion der normalen parotis. ROFO 1973; 119: 165–174.
Greyson ND, Noyek AM. Radionuclide salivary scanning. J Otolaryngol 1982; 11 (suppl. 10): 1–47.
De Rossi G, Focacci C. A computer-assisted method for semi-quantitative assessment of salivary gland diseases. Eur J Nucl Med 1980; 5: 499–503.
Arrago JP, Rain JD, Brocheriou C, Rocher F. Scintigraphy of the salivary glands in Sjögren’s syndrome. J Clin Pathol 1987; 40: 1463–1467.
Schneider P, Traurig G, Haas JP. Quantitative funktionsszintigraphie der Speicheldrüsen. I. Die bestimmung der globalen und regionalen drüsenfunktion. ROFO 1984; 140: 93–96.
Chisin R, Markitziu A, Hoffer S, Shani J, Atlan H. The clinical value of quantitative dynamic scintigraphy in salivary gland disorders. Int J Rad Appl Instrum 1988; 15: 313–317.
Pilbrow WJ, Brownless SM, Cawood JI, Dynes A, Hughes JD, Stockdale HR. Salivary gland scintigraphy — a suitable substitute for sialography? Br J Radiol 1990; 63: 190–196.
Henkin RI, Talal N, Larson AL, Mattern CFT. Abnormalities of taste and smell in Sjögren’s syndrome. Ann Intern Med 1972; 76: 375–383.
Yamashita T, Ino C, Tomoda K, Kumazawa T. Prognostic determination and submandibular function in Bell’s palsy-dynamic testing with technetium-99m. Arch Otolaryngol 1985; 111: 244–248.
Tomita Y, Osaki T. Gustatory impairment and salivary gland pathophysiology in relation to oral cancer treatment. Int J Oral Maxillofac Surg 1990; 19: 299–304.
Peyrin JO. L’exploration radioisotopique dynamique des glandes salivaires. Acta Otorhinolaryngol Belg 1983; 37: 142–151.
Häusler RJ, N’Guyen VT, Ritschard J, Montandon PB. Differential diagnosis of xerostomia by quantitative salivary gland scintigraphy. Ann Otol Rhinol Laryngol 1977; 86: 333–341.
Yoshimura Y, Morishita T, Sugihara T. Salivary gland function after sialolithiasis: scintigraphic examination of submandibular glands with 99mTc-pertechnetate. J Oral Maxillofac Surg 1989; 47: 704–710.
Schall GL. The role of radionuclide scanning in the evaluation of neoplasms of the salivary glands. J Surg Oncol 1971; 3: 699–714.
Magnus L, Schmitt G, Strötges MW, Lehmann G. Die tumordiagnostik der ohrspeicheldrüsen mittels sialographie und sialoszintigraphie. Strahlentherapie 1979; 155: 171–174.
Mishkin FS. Radionuclide salivary gland imaging. Semin Nucl Med 1981; 11: 258–265.
Lunia S, Chodos RB, Lunia C, Chandramouly BS. Oxyphilic adenoma of the parotid gland. Identification with 9mTc-pertechnetate. Radiology 1978; 128: 690.
Higashi T, Murahashi H, Ikuta H, Mori Y, Watanabe Y. Identification of Warthin’s tumor with technetium — 99m pertechnetate. Clin Nucl Med 1987; 12: 796–800.
Dosoretz C, Lieberman LM. Increased uptake of technetium-99m pertechnetate in a salivary gland cancer. Clin Nucl Med 1987; 12: 944–945.
Newman RK, Weiland FL, Johnson JT, Rosen PR, Gumerman LW. Salivary scan after major ablative head and neck surgery with prediction of postoperative fistulization. Ann Otol Rhinol Laryngol 1983; 92: 366–368.
Parret J, Peyrin JO. Radioisotopic investigations in salivary pathology. Clin Nucl Med 1979; 4: 250–261.
Bornemann C, Creutzig H. Die klinische bedeutung einer speicheldrüsenszintigraphie — eine prospective Studie. HNO 1983; 31: 200–206.
Noodt A, Schneider P, Traurig G, Draf W, Haas JP. Quantitative funktionsszintigraphie der Speicheldrüsen -klinische möglichkeiten und derzeitige indikationen. HNO 1985; 33: 232–238.
Van den Akker HP. Diagnostic imaging in salivary gland disease. Oral Surg Oral Med Oral Pathol 1988; 66: 625–637.
Epker BN. Obstructive and inflammatory diseases of the major salivary glands. Oral Surg Oral Med Oral Pathol 1972; 33: 2–27.
Work WP, Hecht DW. Inflammatory diseases of the major salivary glands. In: Paparella MM, Shumrick DA, eds. Otolaryngology, vol. 3. Head and Neck. Philadelphia: WB Saunders; 1980: 2235–2243.
Isacsson G, Lundquist PG. Salivary calculi as an aetiological factor in chronic sialadenitis of the submandibular gland. Clin Otolaryngol 1982; 7: 231–236.
Seldin HW, Seldin SD, Rakower W. Conservative surgery for the removal of salivary calculi. Oral Surg Oral Med Oral Pathol 1953; 6: 579–587.
Seward GR. Anatomic surgery for salivary calculi. Part III. Calculi in the posterior part of the submandibular duct. Oral Surg Oral Med Oral Pathol 1968; 25: 525–531.
Laudenbach P, Chargari S, Allard P. Exérèse des calculs sous-maxillaires posterieurs par voie buccale: a propos de 10 cas. Rev Stomatol Chir Maxillofac 1979; 80: 334–343.
Van den Akker HP, Busemann-Sokole E. Submandibular gland function following transoral sialolithectomy. Oral Surg Oral Med Oral Pathol 1983; 56: 351–356.
Nishi M, Mimura T, Marutani K, Noikura T. Evaluation of submandibular gland function by sialo-scintigraphy following sialolithectomy. J Oral Maxillofac Surg 1987; 45: 567–571.
De Jager JP, Choy D, Fleming A. Salivary scanning in rheumatoid arthritis with sicca syndrome. Ann Rheum Dis 1984; 43: 610–612.
Lindvall AM, Jonsson R. The salivary gland component of Sjögren’s syndrome: an evaluation of diagnostic methods. Oral Surg Oral Med Oral Pathol 1986; 62: 32–42.
Sugihara T, Yoshimura Y. Scintigraphic evaluation of the salivary glands in patients with Sjögren’s syndrome. Int J Oral Maxillofac Surg 1988; 17: 71–75.
Schiodt M, Thorn J. Criteria for the salivary component of Sjögren’s syndrome. A review. Clin Exp Rheumatol 1989; 7: 119–122.
Schall GL, Smith RR, Barsocchini LM. Radionuclide salivary imaging usefulness in a private otolaryngology practice. Arch Otolaryngol 1981; 107: 40–44.
Daniels TE. Labial salivary gland biopsy in Sjögren’s syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27: 147–156.
Scully C. Oral parameters in the diagnosis of Sjögren’s syndrome. Clin Exp Rheumatol 1989; 7: 113–117.
Havlik E, Scherak O, Bergmann H, Kolarz G. Technetiumspeicherung der parotis-wertigkeit von funktionsparametern beim Sjögren-syndrom. Nuklearmedizin 1976; 15: 142–145.
De Rossi G, Salvatori M, Valenza V. Radioisotope studies under pathologic conditions. In: De Rossi G, ed. Radioisotope study of salivary glands. Boca Raton, Florida: CRC Press; 1987: 47–81.
Batsakis JG. Sialadenosis. Ann Otol Rhinol Laryngol 1988; 97: 94–95.
Schulz HG. Das röntgenbild der kopfspeicheldrüsen. Leipzig: Johann Ambrosius Barth; 1969: 17.
Suzuki S, Kawashima K. Sialographic study of diseases of the major salivary glands. Acta Radiol (Diagn) 1969; 8: 465–478.
Smith NJD, Smith PB. Congenital absence of major salivary glands. Br Dent J 1977; 142: 259–260.
Sucupira MS, Weinreb JW, Camargo EE, Wagner HN. Salivary gland imaging and radionuclide dacryocystography in agenesis of salivary glands. Arch Otolaryngol 1983; 109: 197–198.
McDonald FG, Mantas J, McEwen CG, Ferguson MM. Salivary gland aplasia: an ectodermal disorder? J Oral Pathol 1986; 15: 115–117.
Wiesenfeld D, Iverson ES, Ferguson MM, Hardman FG, McMillan NC, Sagar JA. Familial parotid gland aplasia. J Oral Med 1985; 40: 84–85.
Wiesenfeld D, Ferguson MM, Allan CJ, McMillan NC, Scully CM. Bilateral parotid gland aplasia. Br J Oral Surg 1983; 21: 175–178.
Higashino H, Horii T, Ohkusa Y, Ohkuma H, Ino C, Nakazawa M, et al. Congenital absence of lacrimal puncta and of all major salivary glands: case report and literature review. Clin Pediatr 1987; 26: 366–368.
Karlsson G, Lind M. Salivary gland scintigraphy: diagnostic verification of parotid saliva flow through the maxillary sinus and nose. Arch Otorhinolaryngol 1978; 218: 263–267.
Jung H, Meyzis L. Möglichkeiten und grenzen der kopfspeicheldrüsenszintigraphie mit der szintillationskamera. Laryngol Rhinol Otol 1976; 55: 42–48.
Dundas DF, Peterson RA. Surgical treatment of drooling by bilateral parotid duct ligation and submandibular gland resection. Plast Reconstr Surg 1979; 64: 47–51.
Blair GS, Wood GD. Obstructive sialadenitis. Int J Oral Surg 1980; 9: 63–67.
Pogrel MA. Sialodochoplasty — does it work? Int J Oral Maxillofac Surg 1987; 16: 266–269.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Van den Akker, H.P., Busemann-Sokole, E. (1991). Salivary gland scintigraphy with 99mTc-pertechnetate. In: Graamans, K., Van Den Akker, H.P. (eds) Diagnosis of salivary gland disorders. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3608-2_6
Download citation
DOI: https://doi.org/10.1007/978-94-011-3608-2_6
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5600-7
Online ISBN: 978-94-011-3608-2
eBook Packages: Springer Book Archive